Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.

Pinzani P, Salvianti F, Cascella R, Massi D, De Giorgi V, Pazzagli M, Orlando C.

Clin Chim Acta. 2010 Sep 6;411(17-18):1319-24. doi: 10.1016/j.cca.2010.05.024. Epub 2010 May 31.

PMID:
20576522
2.

Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.

Yancovitz M, Yoon J, Mikhail M, Gai W, Shapiro RL, Berman RS, Pavlick AC, Chapman PB, Osman I, Polsky D.

J Mol Diagn. 2007 Apr;9(2):178-83.

3.

Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneity.

Fusi A, Berdel R, Havemann S, Nonnenmacher A, Keilholz U.

Eur J Cancer. 2011 Sep;47(13):1971-6. doi: 10.1016/j.ejca.2011.04.013. Epub 2011 May 12.

PMID:
21570823
4.

Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma.

Halait H, Demartin K, Shah S, Soviero S, Langland R, Cheng S, Hillman G, Wu L, Lawrence HJ.

Diagn Mol Pathol. 2012 Mar;21(1):1-8. doi: 10.1097/PDM.0b013e31823b216f.

PMID:
22306669
5.

BRAFV600E detection in melanoma is highly improved by COLD-PCR.

Pinzani P, Santucci C, Mancini I, Simi L, Salvianti F, Pratesi N, Massi D, De Giorgi V, Pazzagli M, Orlando C.

Clin Chim Acta. 2011 May 12;412(11-12):901-5. doi: 10.1016/j.cca.2011.01.014. Epub 2011 Jan 22.

PMID:
21262211
6.

Molecular platforms utilized to detect BRAF V600E mutation in melanoma.

Curry JL, Torres-Cabala CA, Tetzlaff MT, Bowman C, Prieto VG.

Semin Cutan Med Surg. 2012 Dec;31(4):267-73. doi: 10.1016/j.sder.2012.07.007.

PMID:
23174497
7.

Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.

Sanmamed MF, Fernández-Landázuri S, Rodríguez C, Zárate R, Lozano MD, Zubiri L, Perez-Gracia JL, Martín-Algarra S, González A.

Clin Chem. 2015 Jan;61(1):297-304. doi: 10.1373/clinchem.2014.230235. Epub 2014 Nov 19.

8.

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation.

Venesio T, Chiorino G, Balsamo A, Zaccagna A, Petti C, Scatolini M, Pisacane A, Sarotto I, Picciotto F, Risio M.

Mod Pathol. 2008 Jun;21(6):716-26. doi: 10.1038/modpathol.2008.41. Epub 2008 Apr 11.

9.

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.

Pisareva E, Gutkina N, Kovalenko S, Kuehnapfel S, Hartmann A, Heinzerling L, Schneider-Stock R, Lyubchenko L, Shamanin VA.

Melanoma Res. 2014 Aug;24(4):322-31. doi: 10.1097/CMR.0000000000000090.

PMID:
24922189
10.

Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations.

Pinzani P, Salvianti F, Zaccara S, Massi D, De Giorgi V, Pazzagli M, Orlando C.

Clin Chim Acta. 2011 Nov 20;412(23-24):2141-5. doi: 10.1016/j.cca.2011.07.027. Epub 2011 Aug 3.

PMID:
21839068
11.

An inexpensive, specific and highly sensitive protocol to detect the BrafV600E mutation in melanoma tumor biopsies and blood.

Panka DJ, Sullivan RJ, Mier JW.

Melanoma Res. 2010 Oct;20(5):401-7. doi: 10.1097/CMR.0b013e32833d8d48.

12.

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).

Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G, Vitale M.

Eur J Endocrinol. 2006 Feb;154(2):341-8.

13.

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

Si L, Kong Y, Xu X, Flaherty KT, Sheng X, Cui C, Chi Z, Li S, Mao L, Guo J.

Eur J Cancer. 2012 Jan;48(1):94-100. doi: 10.1016/j.ejca.2011.06.056. Epub 2011 Jul 23.

PMID:
21788131
14.

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.

Lamy PJ, Castan F, Lozano N, Montélion C, Audran P, Bibeau F, Roques S, Montels F, Laberenne AC.

J Mol Diagn. 2015 Jul;17(4):366-73. doi: 10.1016/j.jmoldx.2015.02.004. Epub 2015 May 5.

PMID:
25952101
15.

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.

Shinozaki M, Fujimoto A, Morton DL, Hoon DS.

Clin Cancer Res. 2004 Mar 1;10(5):1753-7.

16.

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.

Am J Surg Pathol. 2013 Jan;37(1):61-5. doi: 10.1097/PAS.0b013e31826485c0.

PMID:
23026937
17.

BRAF mutations in conjunctival melanoma.

Gear H, Williams H, Kemp EG, Roberts F.

Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2484-8.

PMID:
15277467
18.

Benign nodal nevi frequently harbor the activating V600E BRAF mutation.

Taube JM, Begum S, Shi C, Eshleman JR, Westra WH.

Am J Surg Pathol. 2009 Apr;33(4):568-71. doi: 10.1097/PAS.0b013e31818a64fb.

PMID:
19033861
19.

Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.

Jarry A, Masson D, Cassagnau E, Parois S, Laboisse C, Denis MG.

Mol Cell Probes. 2004 Oct;18(5):349-52.

PMID:
15294323
20.

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

Bösmüller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, Bonzheim I, Staebler A, Fend F.

Hum Pathol. 2013 Mar;44(3):329-35. doi: 10.1016/j.humpath.2012.07.010. Epub 2012 Oct 22.

PMID:
23089489
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk